Ignite Creation Date:
2025-12-24 @ 5:37 PM
Ignite Modification Date:
2026-02-23 @ 10:07 PM
Study NCT ID:
NCT02700568
Status:
COMPLETED
Last Update Posted:
2019-10-22
First Post:
2016-01-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Axitinib in Metastatic Renal Cell Carcinoma Patients With Favorable Prognostic Factors
Sponsor:
Kidney Cancer Research Bureau
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
FAVORAX-1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None